Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	TRERF1 KMT2C NCOA6 MRTFB BRD4 MED14 SMARCA4 MAML2 BCL9 KAT6B MED7 MAML3	3.69e-11	303	56	12	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 KMT2C NCOA6 MRTFB BRD4 MED14 SMARCA4 MAML2 BCL9 KAT6B MED7 MAML3	3.97e-08	562	56	12	GO:0003712
GeneOntologyMolecularFunction	molecular adaptor activity	TRERF1 MAGI2 KMT2C NCOA6 MRTFB GAS2L3 RBM33 BRD4 ITSN2 MED14 SMARCA4 TOLLIP MAML2 BCL9 KAT6B MED7 MAML3	9.73e-08	1356	56	17	GO:0060090
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TRERF1 MAGI2 KMT2C NCOA6 MRTFB GAS2L3 RBM33 BRD4 MED14 SMARCA4 MAML2 BCL9 KAT6B MED7 MAML3	4.52e-07	1160	56	15	GO:0030674
GeneOntologyMolecularFunction	chromatin binding	TRIM33 NCOA6 ZC3H4 TP63 BRD4 SMARCA4 UPF1 REST KAT6B RAD21	3.46e-05	739	56	10	GO:0003682
GeneOntologyMolecularFunction	insulin binding	INSR C2CD2L	7.68e-05	5	56	2	GO:0043559
GeneOntologyMolecularFunction	lncRNA binding	RBM33 SMARCA4 RAD21	1.28e-04	35	56	3	GO:0106222
GeneOntologyMolecularFunction	nuclear receptor binding	TRERF1 NCOA6 MED14 SMARCA4 NR4A3	1.77e-04	187	56	5	GO:0016922
GeneOntologyMolecularFunction	core promoter sequence-specific DNA binding	KLF10 SMARCA4 REST	4.94e-04	55	56	3	GO:0001046
GeneOntologyMolecularFunction	peptide hormone binding	INSR LEPR C2CD2L	4.94e-04	55	56	3	GO:0017046
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	TRERF1 NCOA6 MED14	6.70e-04	61	56	3	GO:0030374
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	TRERF1 NCOA6 MED14 SMARCA4 NR4A3 REST	1.08e-03	417	56	6	GO:0061629
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 MED14	1.15e-03	18	56	2	GO:0042809
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TRERF1 NCOA6 MED14 SMARCA4 NR4A3 REST RAD21	1.16e-03	582	56	7	GO:0140297
GeneOntologyMolecularFunction	SUMO binding	SOBP TOLLIP	1.28e-03	19	56	2	GO:0032183
GeneOntologyMolecularFunction	p53 binding	TP63 BRD4 SMARCA4	1.32e-03	77	56	3	GO:0002039
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NCOA6 NR4A3	1.42e-03	20	56	2	GO:0035259
GeneOntologyMolecularFunction	promoter-specific chromatin binding	TRIM33 ZC3H4 TP63	1.64e-03	83	56	3	GO:1990841
GeneOntologyMolecularFunction	protein-hormone receptor activity	INSR LEPR	1.72e-03	22	56	2	GO:0016500
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase binding	MAGI2 NEO1	2.59e-03	27	56	2	GO:0070696
GeneOntologyMolecularFunction	hormone binding	INSR LEPR C2CD2L	3.03e-03	103	56	3	GO:0042562
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BRD4 SMARCA4	3.20e-03	30	56	2	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BRD4 SMARCA4	3.41e-03	31	56	2	GO:0140033
GeneOntologyMolecularFunction	receptor serine/threonine kinase binding	MAGI2 NEO1	4.33e-03	35	56	2	GO:0033612
GeneOntologyMolecularFunction	transcription factor binding	TRERF1 NCOA6 MED14 SMARCA4 NR4A3 REST RAD21	4.91e-03	753	56	7	GO:0008134
GeneOntologyMolecularFunction	chromatin-protein adaptor activity	NCOA6 BRD4	5.91e-03	41	56	2	GO:0140463
GeneOntologyBiologicalProcess	somatic stem cell population maintenance	KLF10 TP63 MED14 REST BCL9 MED7	4.70e-07	108	56	6	GO:0035019
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TRERF1 KMT2C NCOA6 MRTFB KLF10 TP63 BRD4 MED14 SMARCA4 NR4A3 MAML2 REST BCL9 KAT6B MED7 MAML3	5.26e-07	1390	56	16	GO:0045944
GeneOntologyBiologicalProcess	stem cell population maintenance	KLF10 TP63 MED14 SMARCA4 REST BCL9 MED7	3.48e-06	237	56	7	GO:0019827
GeneOntologyBiologicalProcess	maintenance of cell number	KLF10 TP63 MED14 SMARCA4 REST BCL9 MED7	3.99e-06	242	56	7	GO:0098727
GeneOntologyBiologicalProcess	developmental growth	STK3 MAGI2 BNC2 KMT2C ATXN2 BRD4 ITSN2 INSR SMARCA4 BCL9 LEPR	2.82e-05	911	56	11	GO:0048589
GeneOntologyBiologicalProcess	embryonic organ development	STK3 NCOA6 MRTFB SOBP ROR2 SMARCA4 NR4A3 REST	1.28e-04	561	56	8	GO:0048568
GeneOntologyBiologicalProcess	positive regulation of transcription of Notch receptor target	MAML2 MAML3	1.51e-04	7	56	2	GO:0007221
GeneOntologyBiologicalProcess	regulation of miRNA metabolic process	MRTFB RC3H1 SMARCA4 REST	1.76e-04	103	56	4	GO:2000628
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription elongation	ZC3H4 BRD4 MED14 MED7	1.90e-04	105	56	4	GO:0032784
GeneOntologyBiologicalProcess	regulation of T-helper 17 type immune response	RC3H1 BRD4 IL27RA	2.82e-04	47	56	3	GO:2000316
GeneOntologyBiologicalProcess	miRNA metabolic process	MRTFB RC3H1 SMARCA4 REST	3.07e-04	119	56	4	GO:0010586
GeneOntologyBiologicalProcess	positive regulation of stem cell population maintenance	TP63 SMARCA4 REST	3.60e-04	51	56	3	GO:1902459
GeneOntologyBiologicalProcess	positive regulation of insulin secretion involved in cellular response to glucose stimulus	NCOA6 LEPR C2CD2L	3.60e-04	51	56	3	GO:0035774
GeneOntologyBiologicalProcess	hemopoiesis	STK3 NCOA6 KLF10 PRRC2C RC3H1 BRD4 ROR2 SMARCA4 REST KAT6B LEPR	3.84e-04	1223	56	11	GO:0030097
GeneOntologyBiologicalProcess	embryo development	STK3 NCOA6 MRTFB SOBP TP63 BRD4 ROR2 INSR SMARCA4 NR4A3 REST NMT1	3.95e-04	1437	56	12	GO:0009790
GeneOntologyBiologicalProcess	inner ear morphogenesis	SOBP ROR2 NR4A3 REST	4.17e-04	129	56	4	GO:0042472
GeneOntologyBiologicalProcess	growth	STK3 MAGI2 BNC2 KMT2C ATXN2 BRD4 ITSN2 INSR SMARCA4 BCL9 LEPR	4.18e-04	1235	56	11	GO:0040007
GeneOntologyBiologicalProcess	positive regulation of transcription elongation by RNA polymerase II	BRD4 MED14 MED7	4.26e-04	54	56	3	GO:0032968
GeneOntologyBiologicalProcess	primitive hemopoiesis	STK3 SMARCA4	4.70e-04	12	56	2	GO:0060215
GeneOntologyBiologicalProcess	cellular response to steroid hormone stimulus	TRERF1 TP63 SMARCA4 NR4A3 REST	4.73e-04	239	56	5	GO:0071383
GeneOntologyBiologicalProcess	viral transcription	BRD4 SMARCA4 REST	5.26e-04	58	56	3	GO:0019083
GeneOntologyCellularComponent	cis-Golgi network	GBF1 MAP6 SEC23IP BCL9	7.41e-05	85	55	4	GO:0005801
GeneOntologyCellularComponent	nuclear protein-containing complex	TRERF1 KMT2C NCOA6 AFF2 SF3A1 BRD4 MED14 SMARCA4 UPF1 BCL9 SNRPA MED7	1.97e-04	1377	55	12	GO:0140513
GeneOntologyCellularComponent	chromatin	TRIM33 BNC2 KLF10 ZFHX4 TP63 BRD4 SMARCA4 NR4A3 UPF1 REST KAT6B RAD21	3.83e-04	1480	55	12	GO:0000785
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C NCOA6	4.41e-04	12	55	2	GO:0044666
GeneOntologyCellularComponent	transcription regulator complex	TRERF1 NCOA6 MED14 NR4A3 REST BCL9 MED7	9.16e-04	596	55	7	GO:0005667
HumanPheno	Abnormal labia morphology	TP63 BRD4 ROR2 INSR KAT6B RAD21	9.87e-07	88	21	6	HP:0000058
HumanPheno	Abnormality of dental eruption	KMT2C TP63 BRD4 ROR2 INSR SMARCA4 KAT6B RAD21	2.58e-06	240	21	8	HP:0006292
HumanPheno	Labial hypoplasia	TP63 BRD4 ROR2 KAT6B RAD21	4.66e-06	64	21	5	HP:0000066
HumanPheno	Hypoplastic female external genitalia	TP63 BRD4 ROR2 KAT6B RAD21	6.30e-06	68	21	5	HP:0012815
HumanPheno	Hypoplastic labia majora	TP63 BRD4 ROR2 RAD21	1.29e-05	37	21	4	HP:0000059
HumanPheno	Abnormal labia majora morphology	TP63 BRD4 ROR2 RAD21	2.85e-05	45	21	4	HP:0012881
HumanPheno	Abnormal female external genitalia morphology	TP63 BRD4 ROR2 INSR KAT6B RAD21	3.32e-05	161	21	6	HP:0000055
HumanPheno	Abnormality of the urethra	BNC2 TP63 BRD4 ROR2 SMARCA4 REST KAT6B ZMYM3 RAD21	4.41e-05	465	21	9	HP:0000795
HumanPheno	Volvulus	BRD4 ZMYM3 RAD21	5.61e-05	19	21	3	HP:0002580
HumanPheno	Hypospadias	TP63 BRD4 ROR2 SMARCA4 REST KAT6B ZMYM3 RAD21	7.21e-05	377	21	8	HP:0000047
HumanPheno	Displacement of the urethral meatus	TP63 BRD4 ROR2 SMARCA4 REST KAT6B ZMYM3 RAD21	1.04e-04	397	21	8	HP:0100627
HumanPheno	Abnormal male urethral meatus morphology	TP63 BRD4 ROR2 SMARCA4 REST KAT6B ZMYM3 RAD21	1.08e-04	399	21	8	HP:0032076
HumanPheno	Bilateral single transverse palmar creases	BRD4 ROR2 KAT6B RAD21	1.09e-04	63	21	4	HP:0007598
HumanPheno	Long eyelashes	BRD4 ROR2 SMARCA4 SEC31A RAD21	1.42e-04	129	21	5	HP:0000527
HumanPheno	Vesicoureteral reflux	BNC2 KMT2C TP63 BRD4 ZMYM3 RAD21	1.95e-04	221	21	6	HP:0000076
HumanPheno	Hypoplastic sacrum	TP63 ROR2	2.40e-04	6	21	2	HP:0004590
HumanPheno	Oligodactyly	TP63 BRD4 RAD21	3.04e-04	33	21	3	HP:0012165
HumanPheno	Thick eyebrow	KMT2C TP63 BRD4 SMARCA4 RAD21	3.25e-04	154	21	5	HP:0000574
HumanPheno	Abnormal ureter physiology	BNC2 KMT2C TP63 BRD4 ZMYM3 RAD21	3.43e-04	245	21	6	HP:0025634
HumanPheno	Supernumerary tooth	KMT2C TP63 ROR2 RAD21	3.48e-04	85	21	4	HP:0011069
HumanPheno	Aplasia/Hypoplasia of the phalanges of the toes	TP63 ROR2 SMARCA4	3.95e-04	36	21	3	HP:0010173
HumanPheno	Abnormality of the lower urinary tract	BNC2 KMT2C ATXN2 TP63 BRD4 ROR2 SMARCA4 REST KAT6B ZMYM3 RAD21	4.46e-04	937	21	11	HP:0010936
HumanPheno	Labial hypertrophy	INSR KAT6B	4.47e-04	8	21	2	HP:0000065
HumanPheno	Hypoplastic nipples	TP63 BRD4 RAD21	5.02e-04	39	21	3	HP:0002557
HumanPheno	Severe postnatal growth retardation	BRD4 INSR RAD21	5.41e-04	40	21	3	HP:0008850
HumanPheno	Abnormal male external genitalia morphology	BNC2 KMT2C TP63 BRD4 ROR2 INSR SMARCA4 SEC31A REST KAT6B LEPR ZMYM3 RAD21	5.67e-04	1329	21	13	HP:0000032
HumanPheno	Ventricular septal defect	TP63 BRD4 ROR2 INSR SMARCA4 SEC31A KAT6B RAD21	5.97e-04	510	21	8	HP:0001629
HumanPheno	Multicystic kidney dysplasia	BRD4 ROR2 KAT6B RAD21	6.00e-04	98	21	4	HP:0000003
HumanPheno	Abnormal clitoris morphology	TP63 ROR2 INSR KAT6B	6.47e-04	100	21	4	HP:0000056
HumanPheno	Abnormal ventricular septum morphology	TP63 BRD4 ROR2 INSR SMARCA4 SEC31A KAT6B RAD21	6.90e-04	521	21	8	HP:0010438
HumanPheno	Proximal placement of thumb	TP63 BRD4 RAD21	7.18e-04	44	21	3	HP:0009623
HumanPheno	Delayed eruption of teeth	BRD4 ROR2 SMARCA4 KAT6B RAD21	7.58e-04	185	21	5	HP:0000684
HumanPheno	Abnormal eyelash morphology	TP63 BRD4 ROR2 SMARCA4 SEC31A RAD21	7.58e-04	284	21	6	HP:0000499
HumanPheno	Abnormal external genitalia	BNC2 KMT2C TP63 BRD4 ROR2 INSR SMARCA4 SEC31A REST KAT6B LEPR ZMYM3 RAD21	7.92e-04	1372	21	13	HP:0000811
MousePheno	abnormal mandible morphology	AMELX ZFHX4 TP63 BRD4 ROR2 KAT6B	2.89e-05	176	48	6	MP:0000458
MousePheno	small mandible	ZFHX4 TP63 BRD4 ROR2 KAT6B	4.65e-05	116	48	5	MP:0004592
MousePheno	abnormal palatal shelf morphology	BNC2 NCOA6 ZFHX4 TP63 ROR2	5.69e-05	121	48	5	MP:0031460
MousePheno	abnormal secondary palate development	BNC2 NCOA6 ZFHX4 TP63 ROR2	6.39e-05	124	48	5	MP:0009655
MousePheno	abnormal palate development	BNC2 NCOA6 ZFHX4 TP63 ROR2	7.71e-05	129	48	5	MP:0009653
Domain	Neuroggenic_mastermind-like_N	MAML2 MAML3	2.64e-05	3	56	2	IPR019082
Domain	MamL-1	MAML2 MAML3	2.64e-05	3	56	2	PF09596
Domain	MamL-1	MAML2 MAML3	2.64e-05	3	56	2	SM01275
Domain	DUF3504	ZMYM4 ZMYM3	8.78e-05	5	56	2	IPR021893
Domain	DUF3504	ZMYM4 ZMYM3	8.78e-05	5	56	2	PF12012
Domain	Znf_MYM	ZMYM4 ZMYM3	1.84e-04	7	56	2	IPR010507
Domain	zf-FCS	ZMYM4 ZMYM3	1.84e-04	7	56	2	PF06467
Domain	BROMODOMAIN_1	TRIM33 BRD4 SMARCA4	1.85e-04	37	56	3	PS00633
Domain	Bromodomain	TRIM33 BRD4 SMARCA4	2.00e-04	38	56	3	PF00439
Domain	TRASH_dom	ZMYM4 ZMYM3	2.44e-04	8	56	2	IPR011017
Domain	TRASH	ZMYM4 ZMYM3	2.44e-04	8	56	2	SM00746
Domain	HEMATOPO_REC_L_F2	LEPR IL27RA	2.44e-04	8	56	2	PS01353
Domain	BROMODOMAIN_2	TRIM33 BRD4 SMARCA4	2.51e-04	41	56	3	PS50014
Domain	BROMO	TRIM33 BRD4 SMARCA4	2.70e-04	42	56	3	SM00297
Domain	Bromodomain	TRIM33 BRD4 SMARCA4	2.70e-04	42	56	3	IPR001487
Domain	-	TRIM33 BRD4 SMARCA4	2.70e-04	42	56	3	1.20.920.10
Domain	PHD	TRIM33 KMT2C KAT6B	1.48e-03	75	56	3	PF00628
Domain	Znf_PHD-finger	TRIM33 KMT2C KAT6B	1.72e-03	79	56	3	IPR019787
Domain	FN3	NEO1 INSR LEPR IL27RA	2.29e-03	185	56	4	SM00060
Domain	PHD	TRIM33 KMT2C KAT6B	2.42e-03	89	56	3	SM00249
Domain	Znf_PHD	TRIM33 KMT2C KAT6B	2.57e-03	91	56	3	IPR001965
Domain	Bromodomain_CS	BRD4 SMARCA4	2.74e-03	26	56	2	IPR018359
Domain	ZF_PHD_2	TRIM33 KMT2C KAT6B	2.91e-03	95	56	3	PS50016
Domain	FN3	NEO1 INSR LEPR IL27RA	2.98e-03	199	56	4	PS50853
Domain	ZF_PHD_1	TRIM33 KMT2C KAT6B	3.00e-03	96	56	3	PS01359
Domain	FN3_dom	NEO1 INSR LEPR IL27RA	3.55e-03	209	56	4	IPR003961
Domain	Znf-RING_LisH	TRIM33 RC3H1	4.66e-03	34	56	2	IPR027370
Domain	zf-RING_UBOX	TRIM33 RC3H1	4.66e-03	34	56	2	PF13445
Domain	-	KAT6B NMT1	6.40e-03	40	56	2	3.40.630.30
Domain	-	ZC3H4 RC3H1	6.40e-03	40	56	2	4.10.1000.10
Domain	Acyl_CoA_acyltransferase	KAT6B NMT1	8.05e-03	45	56	2	IPR016181
Pathway	WP_KLEEFSTRA_SYNDROME	KMT2C NCOA6 SMARCA4	9.80e-05	29	44	3	M48076
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 TRIM33 KMT2C NCOA6 ATXN2 RBM33 PRRC2C SF3A1 BRD4 MED14 SMARCA4 UPF1 BCL9 SNRPA ZMYM4 ZMYM3 RAD21	8.99e-13	1103	56	17	34189442
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 NCOA6 GBF1 ZC3H4 SF3A1 BRD4 YLPM1 MED14 SMARCA4 REST BCL9 KAT6B NMT1 ZMYM4 ZMYM3	9.92e-13	774	56	15	15302935
Pubmed	Human transcription factor protein interaction networks.	TRERF1 TRIM33 KMT2C NCOA6 KLF10 ZFHX4 ATXN2 RBM33 SOBP PRRC2C RC3H1 YLPM1 SMARCA4 UPF1 BCL9 ZMYM4 ZMYM3 RAD21	4.82e-12	1429	56	18	35140242
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 TRIM33 NCOA6 RBM33 ZC3H4 BRD4 YLPM1 MED14 SMARCA4 BCL9	1.63e-11	268	56	10	33640491
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TRIM33 KMT2C NCOA6 ATXN2 RBM33 PRRC2C RC3H1 YLPM1 SEC23IP BCL9 MAML3	1.57e-10	457	56	11	32344865
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 TRIM33 KMT2C NCOA6 ZFHX4 SOBP SMARCA4 BCL9 ZMYM4 ZMYM3	2.28e-10	351	56	10	38297188
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 MAGI2 PRR36 ATXN2 MAP6 ZC3H4 PRRC2C YLPM1 SEC23IP SMARCA4 SEC31A UPF1 FRMPD3 BCL9	2.79e-10	963	56	14	28671696
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KMT2C NCOA6 MRTFB PRRC2C BRD4 YLPM1 SEC23IP MED14 SMARCA4 UPF1 ZMYM4	1.08e-09	549	56	11	38280479
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 NCOA6 MRTFB GBF1 AFF2 ATXN2 TP63 YLPM1 MAML2 BCL9	1.61e-09	430	56	10	35044719
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TRIM33 NCOA6 ATXN2 RBM33 ZC3H4 PRRC2C SF3A1 BRD4 YLPM1 SMARCA4 SNRPA ZMYM4 RAD21	2.91e-09	954	56	13	36373674
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	KMT2C NCOA6 MRTFB GBF1 ZC3H4 WASF3 KAT6B C2CD2L	2.95e-09	225	56	8	12168954
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	ATXN2 RBM33 ZC3H4 PRRC2C SF3A1 BRD4 YLPM1 SEC31A SNRPA	1.48e-08	399	56	9	35987950
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	NCOA6 MRTFB RBM33 ZC3H4 SF3A1 BRD4 YLPM1 SMARCA4	1.76e-08	283	56	8	30585729
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	STK3 GBF1 ATXN2 RBM33 ZC3H4 PRRC2C RC3H1 YLPM1 SEC31A UPF1 NMT1	1.88e-08	724	56	11	36232890
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	TRIM33 KMT2C ZC3H4 PRRC2C BRD4 SMARCA4 REST ZMYM4 RAD21	5.90e-08	469	56	9	27634302
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	ATXN2 SF3A1 RC3H1 YLPM1 SEC23IP SMARCA4 BCL9	6.57e-08	220	56	7	24550385
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	TRIM33 KMT2C MED14 SMARCA4 MED7 ZMYM4	2.98e-07	167	56	6	20362541
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TRERF1 MRTFB ZFHX4 BRD4 SEC23IP RUSC1 ZMYM4 ZMYM3	3.49e-07	418	56	8	34709266
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	NCOA6 ATXN2 SF3A1 MED14 SNRPA MED7 RAD21	3.62e-07	283	56	7	18854154
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TRIM33 KMT2C MRTFB ATXN2 RBM33 ITSN2 MED14 TOLLIP NMT1 ZMYM4 ZMYM3 RAD21 C2CD2L	5.54e-07	1497	56	13	31527615
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	ZFHX4 BRD4 SMARCA4 ZMYM4 ZMYM3	7.00e-07	103	56	5	32744500
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	TRIM33 GBF1 RBM33 SEC23IP SMARCA4 SEC31A UPF1 SNRPA RAD21	7.81e-07	638	56	9	33239621
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MAP6 ZC3H4 SF3A1 BRD4 YLPM1 MED14 SMARCA4 SEC31A UPF1 SNRPA ZMYM3	1.04e-06	1082	56	11	38697112
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NCOA6 MRTFB ZC3H4 SF3A1 YLPM1 MED14 KAT6B	1.26e-06	341	56	7	32971831
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	TRIM33 RBM33 BRD4 SMARCA4 ZMYM4 RAD21	1.57e-06	222	56	6	37071664
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TRIM33 KMT2C NCOA6 ZC3H4 MAML2 KAT6B ZMYM4 RAD21	2.03e-06	529	56	8	14621295
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MRTFB ZC3H4 PRRC2C SF3A1 YLPM1 SEC23IP SMARCA4 UPF1 NMT1 RAD21	2.16e-06	934	56	10	33916271
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	NCOA6 PNMA1 MAP6 MED14 NR4A3	2.48e-06	133	56	5	15604093
Pubmed	KLF10 transcription factor regulates hepatic glucose metabolism in mice.	KLF10 LEPR	2.55e-06	2	56	2	28836014
Pubmed	BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.	SMARCA4 REST	2.55e-06	2	56	2	17023429
Pubmed	TP63 Is Significantly Upregulated in Diabetic Kidney.	TP63 LEPR	2.55e-06	2	56	2	33920782
Pubmed	Maternal obesity modulates sexually dimorphic epigenetic regulation and expression of leptin receptor in offspring hippocampus.	INSR LEPR	2.55e-06	2	56	2	32173454
Pubmed	Cross down-regulation of leptin and insulin receptor expression and signalling in a human neuronal cell line.	INSR LEPR	2.55e-06	2	56	2	15715521
Pubmed	Insulin and leptin receptors as possible new candidates for endocrine control in normal and disturbed human pregnancy.	INSR LEPR	2.55e-06	2	56	2	19246519
Pubmed	Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice.	ATXN2 INSR	2.55e-06	2	56	2	18250099
Pubmed	SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing.	SMARCA4 REST	2.55e-06	2	56	2	39080761
Pubmed	Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.	INSR LEPR	2.55e-06	2	56	2	23119079
Pubmed	The ATPase BRG1/SMARCA4 is a protein interaction platform that recruits BAF subunits and the transcriptional repressor REST/NRSF in neural progenitor cells.	SMARCA4 REST	2.55e-06	2	56	2	31428904
Pubmed	Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility.	INSR LEPR	2.55e-06	2	56	2	20374961
Pubmed	Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.	ATXN2 MAP6 UPF1	3.76e-06	19	56	3	34467244
Pubmed	Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.	TRIM33 MED14 SMARCA4 MED7	4.03e-06	66	56	4	23275444
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	RBM33 ZC3H4 SF3A1 BRD4 YLPM1	4.18e-06	148	56	5	32538781
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	TRIM33 ATXN2 RBM33 ITSN2 SEC23IP SEC31A UPF1 BCL9 NMT1 ZMYM4	4.21e-06	1007	56	10	34597346
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	TRIM33 SF3A1 BRD4 YLPM1 SMARCA4 ZMYM4 ZMYM3	4.31e-06	411	56	7	35182466
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ATXN2 RBM33 ZC3H4 PRRC2C SF3A1 RC3H1 YLPM1 UPF1 SNRPA	5.33e-06	807	56	9	22681889
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	KMT2C NCOA6 SF3A1 BRD4 YLPM1 SMARCA4 REST SNRPA ZMYM4 ZMYM3 RAD21	5.79e-06	1294	56	11	30804502
Pubmed	Leptin and insulin do not exert redundant control of metabolic or emotive function via dopamine neurons.	INSR LEPR	7.63e-06	3	56	2	30292429
Pubmed	Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling.	MAML2 MAML3	7.63e-06	3	56	2	12386158
Pubmed	Identification of diabetes susceptibility loci in db mice by combined quantitative trait loci analysis and haplotype mapping.	MRTFB LEPR	7.63e-06	3	56	2	16919419
Pubmed	Insulin signaling in LepR cells modulates fat and glucose homeostasis independent of leptin.	INSR LEPR	7.63e-06	3	56	2	30376348
Pubmed	Distinct networks of leptin- and insulin-sensing neurons regulate thermogenic responses to nutritional and cold challenges.	INSR LEPR	7.63e-06	3	56	2	25125486
Pubmed	Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice.	INSR LEPR	7.63e-06	3	56	2	19188430
Pubmed	Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses.	INSR LEPR	7.63e-06	3	56	2	30418175
Pubmed	Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress.	STK3 TP63	7.63e-06	3	56	2	31212215
Pubmed	The beta secretase BACE1 regulates the expression of insulin receptor in the liver.	INSR LEPR	7.63e-06	3	56	2	29610518
Pubmed	LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.	BRD4 UPF1	7.63e-06	3	56	2	37120495
Pubmed	Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period.	INSR LEPR	7.63e-06	3	56	2	25946091
Pubmed	Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.	KMT2C NCOA6	7.63e-06	3	56	2	18372346
Pubmed	Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.	KMT2C NCOA6	7.63e-06	3	56	2	21330447
Pubmed	Cloning and mapping of members of the MYM family.	ZMYM4 ZMYM3	7.63e-06	3	56	2	10486218
Pubmed	BRD4 inhibition regulates MAPK, NF-κB signals, and autophagy to suppress MMP-13 expression in diabetic intervertebral disc degeneration.	BRD4 LEPR	7.63e-06	3	56	2	31331201
Pubmed	Blood cells as a source of transcriptional biomarkers of childhood obesity and its related metabolic alterations: results of the IDEFICS study.	INSR LEPR	7.63e-06	3	56	2	22278432
Pubmed	Gene expression of leptin, leptin receptor isoforms and inflammatory cytokines in placentas of obese women - Associations to birth weight and fetal sex.	INSR LEPR	7.63e-06	3	56	2	34773742
Pubmed	t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.	MAML2 MAML3	7.63e-06	3	56	2	12539049
Pubmed	5C analysis of the Epidermal Differentiation Complex locus reveals distinct chromatin interaction networks between gene-rich and gene-poor TADs in skin epithelial cells.	SMARCA4 RAD21	7.63e-06	3	56	2	28863138
Pubmed	Neogenin pathway positively regulates fibronectin production by glomerular mesangial cells.	NEO1 LEPR	7.63e-06	3	56	2	35704698
Pubmed	Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1.	SMARCA4 LEPR	7.63e-06	3	56	2	31850346
Pubmed	Inter-organ insulin-leptin signal crosstalk from the liver enhances survival during food shortages.	INSR LEPR	7.63e-06	3	56	2	37116488
Pubmed	Regnase-1 and Roquin regulate inflammatory mRNAs.	RC3H1 UPF1	7.63e-06	3	56	2	26255671
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 TP63 SMARCA4 BCL9	1.01e-05	83	56	4	28794006
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	STK3 ZC3H4 SF3A1 ITSN2 INSR YLPM1 SMARCA4 ZMYM4 ZMYM3 RAD21	1.39e-05	1155	56	10	20360068
Pubmed	Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration.	WASF3 ZMYM4 ZMYM3	1.40e-05	29	56	3	21834987
Pubmed	Acute effects of zinc and insulin on arcuate anorexigenic proopiomelanocortin neurons.	INSR LEPR	1.52e-05	4	56	2	30521677
Pubmed	Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.	TP63 ROR2	1.52e-05	4	56	2	28559016
Pubmed	Dual role of NRSF/REST in activation and repression of the glucocorticoid response.	SMARCA4 REST	1.52e-05	4	56	2	17984088
Pubmed	Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents.	INSR LEPR	1.52e-05	4	56	2	27213816
Pubmed	Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.	BRD4 SMARCA4	1.52e-05	4	56	2	30428346
Pubmed	TOX4, an insulin receptor-independent regulator of hepatic glucose production, is activated in diabetic liver.	INSR LEPR	1.52e-05	4	56	2	34914893
Pubmed	Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms.	RC3H1 UPF1	1.52e-05	4	56	2	26000482
Pubmed	A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism.	INSR LEPR	1.52e-05	4	56	2	32005828
Pubmed	Serotonin 5-HT2C receptor-independent expression of hypothalamic NOR1, a novel modulator of food intake and energy balance, in mice.	NR4A3 LEPR	1.52e-05	4	56	2	19523439
Pubmed	BRG1 (Brahma-Related Gene 1) Promotes Endothelial Mrtf Transcription to Establish Embryonic Capillary Integrity.	MRTFB SMARCA4	1.52e-05	4	56	2	28729363
Pubmed	PKB/Akt phosphorylation of ERRγ contributes to insulin-mediated inhibition of hepatic gluconeogenesis.	INSR LEPR	1.52e-05	4	56	2	25205222
Pubmed	Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.	KLF10 LEPR	1.52e-05	4	56	2	38582490
Pubmed	p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.	TP63 WASF3	1.52e-05	4	56	2	28794159
Pubmed	Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability.	INSR LEPR	1.52e-05	4	56	2	27518562
Pubmed	Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.	INSR LEPR	1.52e-05	4	56	2	23354051
Pubmed	Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.	INSR LEPR	1.52e-05	4	56	2	21346174
Pubmed	Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.	INSR LEPR	1.52e-05	4	56	2	26340929
Pubmed	High-throughput screen for genes predominantly expressed in the ICM of mouse blastocysts by whole mount in situ hybridization.	BNC2 KMT2C SMARCA4 REST	1.65e-05	94	56	4	16325481
Pubmed	Tagging genes with cassette-exchange sites.	BNC2 KMT2C PRRC2C REST KAT6B ZMYM4	1.65e-05	335	56	6	15741177
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	MRTFB RBM33 ZC3H4 SF3A1 BRD4 YLPM1 SMARCA4	1.66e-05	506	56	7	30890647
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KMT2C BRD4 SMARCA4 NR4A3 REST KAT6B MAML3 ZMYM3	1.72e-05	709	56	8	22988430
Pubmed	Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions.	ATXN2 SEC23IP UPF1	1.90e-05	32	56	3	19542561
Pubmed	TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.	BRD4 MED14 SMARCA4	2.08e-05	33	56	3	33567268
Pubmed	DSSylation, a novel protein modification targets proteins induced by oxidative stress, and facilitates their degradation in cells.	TRIM33 ATXN2 RBM33	2.49e-05	35	56	3	24515614
Pubmed	Glucose, insulin, insulin receptor subunits α and β in normal and spontaneously diabetic and obese ob/ob and db/db infertile mouse testis and hypophysis.	INSR LEPR	2.54e-05	5	56	2	32183843
Pubmed	A small modulatory dsRNA specifies the fate of adult neural stem cells.	SMARCA4 REST	2.54e-05	5	56	2	15035981
Pubmed	PI3Kα inactivation in leptin receptor cells increases leptin sensitivity but disrupts growth and reproduction.	INSR LEPR	2.54e-05	5	56	2	29212950
Pubmed	SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.	INSR LEPR	2.54e-05	5	56	2	31217420
Interaction	PABPN1 interactions	ATXN2 RBM33 SF3A1 RC3H1 BRD4 ITSN2 SMARCA4 UPF1 SNRPA	2.33e-09	192	55	9	int:PABPN1
Interaction	NUP35 interactions	TRIM33 KMT2C NCOA6 ATXN2 RBM33 PRRC2C RC3H1 YLPM1 SEC23IP BCL9 MAML3	1.64e-08	424	55	11	int:NUP35
Interaction	CEBPA interactions	TRERF1 TRIM33 KMT2C NCOA6 ATXN2 RBM33 PRRC2C SF3A1 BRD4 MED14 SMARCA4 UPF1 BCL9 SNRPA ZMYM4 ZMYM3 RAD21	1.81e-08	1245	55	17	int:CEBPA
Interaction	SP7 interactions	TRERF1 TRIM33 KMT2C NCOA6 ZFHX4 RBM33 YLPM1 SMARCA4 BCL9	1.24e-07	304	55	9	int:SP7
Interaction	YAP1 interactions	TRERF1 KMT2C NCOA6 MRTFB GBF1 PRRC2C TP63 SF3A1 BRD4 YLPM1 MED14 SMARCA4 TOLLIP UPF1 ZMYM4	1.48e-07	1095	55	15	int:YAP1
Interaction	EGR2 interactions	TRERF1 TRIM33 KMT2C NCOA6 ZFHX4 BCL9 ZMYM4	4.03e-07	171	55	7	int:EGR2
Interaction	RBMX interactions	TRIM33 SF3A1 RC3H1 BRD4 ITSN2 YLPM1 SEC23IP UPF1 REST SNRPA	4.14e-07	461	55	10	int:RBMX
Interaction	CRX interactions	TRERF1 TRIM33 KMT2C ZFHX4 ROR2 BCL9 ZMYM4 ZMYM3	4.16e-07	254	55	8	int:CRX
Interaction	PEG10 interactions	ATXN2 MAP6 RC3H1 TOLLIP UPF1 SNRPA	4.32e-07	106	55	6	int:PEG10
Interaction	ALG13 interactions	ATXN2 RBM33 PRRC2C RC3H1 ROR2 UPF1 BCL9	6.37e-07	183	55	7	int:ALG13
Interaction	TBXT interactions	KMT2C NCOA6 ZFHX4 SMARCA4 BCL9 ZMYM4	7.35e-07	116	55	6	int:TBXT
Interaction	HNF4A interactions	TRIM33 KMT2C NCOA6 MED14 SMARCA4 MED7 ZMYM4 ZMYM3	7.59e-07	275	55	8	int:HNF4A
Interaction	HNRNPA3 interactions	PRRC2C TP63 SF3A1 RC3H1 BRD4 ITSN2 UPF1 REST SNRPA RAD21	1.06e-06	511	55	10	int:HNRNPA3
Interaction	CELF1 interactions	ATXN2 RBM33 ZC3H4 PRRC2C RC3H1 BRD4 YLPM1 UPF1	1.07e-06	288	55	8	int:CELF1
Interaction	AR interactions	TRERF1 TRIM33 KMT2C NCOA6 RBM33 ZC3H4 BRD4 YLPM1 MED14 SMARCA4 TOLLIP BCL9 ZMYM4	1.94e-06	992	55	13	int:AR
Interaction	SMC5 interactions	TRIM33 NCOA6 ATXN2 RBM33 ZC3H4 PRRC2C SF3A1 BRD4 YLPM1 SMARCA4 SNRPA ZMYM4 RAD21	2.12e-06	1000	55	13	int:SMC5
Interaction	SMG7 interactions	NCOA6 ATXN2 RBM33 ZC3H4 RC3H1 YLPM1 UPF1 BCL9	2.30e-06	319	55	8	int:SMG7
Interaction	ERG interactions	TRIM33 KMT2C NCOA6 ZFHX4 BRD4 SMARCA4 BCL9	2.39e-06	223	55	7	int:ERG
Interaction	PABPC1 interactions	TRIM33 KMT2C ATXN2 PRRC2C SF3A1 RC3H1 BRD4 PAPOLB UPF1 REST SNRPA	2.40e-06	699	55	11	int:PABPC1
Interaction	MEN1 interactions	KMT2C NCOA6 MRTFB ZC3H4 SF3A1 YLPM1 MED14 SMARCA4 UPF1 KAT6B ZMYM4 ZMYM3 RAD21	2.91e-06	1029	55	13	int:MEN1
Interaction	SYNCRIP interactions	ATXN2 PRRC2C TP63 SF3A1 RC3H1 BRD4 INSR UPF1 REST SNRPA RAD21	3.24e-06	721	55	11	int:SYNCRIP
Interaction	RBM3 interactions	RC3H1 BRD4 YLPM1 UPF1 REST SNRPA	5.33e-06	163	55	6	int:RBM3
Interaction	LHX4 interactions	TRIM33 KMT2C SMARCA4 BCL9 SNRPA ZMYM4	5.92e-06	166	55	6	int:LHX4
Interaction	PAX6 interactions	KMT2C NCOA6 ZFHX4 SMARCA4 BCL9 ZMYM4 ZMYM3 RAD21	6.34e-06	366	55	8	int:PAX6
Interaction	WWOX interactions	ATXN2 TP63 SF3A1 RC3H1 YLPM1 SEC23IP SMARCA4 RUSC1 UPF1 BCL9	6.54e-06	627	55	10	int:WWOX
Interaction	SOX9 interactions	KMT2C NCOA6 BRD4 SMARCA4 BCL9	6.69e-06	97	55	5	int:SOX9
Interaction	HNRNPD interactions	ATXN2 TP63 RC3H1 BRD4 YLPM1 MED14 SEC31A REST SNRPA ZMYM4	7.62e-06	638	55	10	int:HNRNPD
Interaction	KIF11 interactions	TRIM33 GBF1 RC3H1 BRD4 MED14 TOLLIP BCL9	7.81e-06	267	55	7	int:KIF11
Interaction	IGF2BP1 interactions	ATXN2 PRRC2C TP63 RC3H1 SEC23IP SEC31A UPF1 REST SNRPA	8.68e-06	508	55	9	int:IGF2BP1
Interaction	LHX2 interactions	KMT2C ZFHX4 SMARCA4 BCL9 ZMYM4 RAD21	1.03e-05	183	55	6	int:LHX2
Interaction	DHX9 interactions	TRIM33 ATXN2 TP63 RC3H1 BRD4 UPF1 REST SNRPA NMT1 RAD21	1.05e-05	662	55	10	int:DHX9
Interaction	CSDE1 interactions	TRIM33 GBF1 ATXN2 PRRC2C RC3H1 BRD4 UPF1	1.17e-05	284	55	7	int:CSDE1
Interaction	HNRNPR interactions	TRIM33 ATXN2 TP63 SF3A1 RC3H1 BRD4 UPF1 REST SNRPA	1.33e-05	536	55	9	int:HNRNPR
Interaction	TBR1 interactions	KMT2C ZFHX4 BRD4 BCL9 ZMYM4	1.41e-05	113	55	5	int:TBR1
Interaction	KLF5 interactions	KMT2C NCOA6 TP63 BRD4 BCL9 ZMYM4	1.49e-05	195	55	6	int:KLF5
Interaction	FUBP3 interactions	ATXN2 RBM33 PRRC2C RC3H1 BRD4 YLPM1 UPF1	1.56e-05	297	55	7	int:FUBP3
Interaction	ALYREF interactions	RBM33 SF3A1 RC3H1 BRD4 UPF1 REST SNRPA RAD21	1.61e-05	416	55	8	int:ALYREF
Interaction	TERF2IP interactions	TRIM33 NCOA6 ZC3H4 BRD4 SMARCA4 SNRPA ZMYM4 ZMYM3 RAD21	1.68e-05	552	55	9	int:TERF2IP
Interaction	YTHDF1 interactions	ATXN2 PRRC2C RC3H1 ITSN2 TOLLIP UPF1 SNRPA	1.74e-05	302	55	7	int:YTHDF1
Interaction	RNF2 interactions	NCOA6 ZC3H4 SF3A1 BRD4 MED14 SMARCA4 UPF1 REST SNRPA ZMYM3 RAD21	1.83e-05	866	55	11	int:RNF2
Interaction	FEV interactions	KMT2C NCOA6 ZFHX4 BCL9 ZMYM4 ZMYM3	1.86e-05	203	55	6	int:FEV
Interaction	DDX17 interactions	TRIM33 ATXN2 SF3A1 RC3H1 BRD4 YLPM1 REST SNRPA	1.90e-05	426	55	8	int:DDX17
Interaction	SFPQ interactions	PRRC2C SF3A1 RC3H1 BRD4 YLPM1 SMARCA4 REST SNRPA RAD21	1.97e-05	563	55	9	int:SFPQ
Interaction	SOX2 interactions	TRERF1 TRIM33 KMT2C NCOA6 ZFHX4 GAS2L3 TP63 YLPM1 SMARCA4 TOLLIP UPF1 BCL9 KAT6B RAD21	1.99e-05	1422	55	14	int:SOX2
Interaction	EIF4G1 interactions	TRIM33 GBF1 ATXN2 SF3A1 RC3H1 BRD4 YLPM1 RAD21	2.14e-05	433	55	8	int:EIF4G1
Interaction	WDR82 interactions	KMT2C NCOA6 ZC3H4 SF3A1 BRD4 SNRPA	2.45e-05	213	55	6	int:WDR82
Interaction	H3C1 interactions	TRIM33 KMT2C ZC3H4 PRRC2C BRD4 MED14 SMARCA4 KAT6B SNRPA ZMYM4 RAD21	2.64e-05	901	55	11	int:H3C1
Interaction	EWSR1 interactions	TRIM33 NCOA6 RBM33 RC3H1 BRD4 SMARCA4 UPF1 REST BCL9 SNRPA RAD21	2.78e-05	906	55	11	int:EWSR1
Interaction	SUMO2 interactions	TRIM33 SOBP SF3A1 BRD4 SMARCA4 UPF1 ZMYM4 ZMYM3 RAD21	2.88e-05	591	55	9	int:SUMO2
Interaction	FUS interactions	NCOA6 ZC3H4 TP63 SF3A1 RC3H1 BRD4 YLPM1 SMARCA4 UPF1 SNRPA	3.33e-05	757	55	10	int:FUS
Interaction	CNOT9 interactions	GBF1 ATXN2 PRRC2C RC3H1 SEC23IP UPF1	3.85e-05	231	55	6	int:CNOT9
Interaction	RBM8A interactions	ATXN2 RBM33 PRRC2C SF3A1 BRD4 YLPM1 UPF1 SNRPA	4.01e-05	473	55	8	int:RBM8A
Interaction	PARP1 interactions	TRIM33 NCOA6 SF3A1 RC3H1 BRD4 MED14 SMARCA4 SEC31A REST MED7 ZMYM4 ZMYM3 RAD21	4.06e-05	1316	55	13	int:PARP1
Interaction	NCBP2 interactions	SF3A1 RC3H1 BRD4 UPF1 SNRPA	4.10e-05	141	55	5	int:NCBP2
Interaction	PLS3 interactions	TRIM33 GBF1 ATXN2 PRRC2C TP63 SEC31A	4.45e-05	237	55	6	int:PLS3
Interaction	CSNK2A1 interactions	GBF1 ATXN2 RBM33 ZC3H4 PRRC2C TP63 SF3A1 BRD4 SMARCA4 UPF1 NMT1	4.54e-05	956	55	11	int:CSNK2A1
Interaction	SNRPA interactions	ZC3H4 PRRC2C TP63 SF3A1 RC3H1 BRD4 YLPM1 SNRPA	4.58e-05	482	55	8	int:SNRPA
Interaction	DAZL interactions	ATXN2 RBM33 PRRC2C RC3H1 UPF1	4.69e-05	145	55	5	int:DAZL
Interaction	NCBP1 interactions	ATXN2 SF3A1 RC3H1 BRD4 SEC23IP UPF1 SNRPA	4.70e-05	353	55	7	int:NCBP1
Interaction	NXF1 interactions	TRERF1 ATXN2 RBM33 SF3A1 BRD4 ROR2 YLPM1 SEC31A UPF1 SNRPA NMT1 ZMYM4 ZMYM3	5.09e-05	1345	55	13	int:NXF1
Interaction	NCOR1 interactions	TRIM33 SF3A1 BRD4 SEC23IP SMARCA4 SEC31A REST	5.60e-05	363	55	7	int:NCOR1
Interaction	DDX3X interactions	TRIM33 ATXN2 PRRC2C RC3H1 BRD4 UPF1 REST SNRPA RAD21	6.10e-05	651	55	9	int:DDX3X
Interaction	HNRNPAB interactions	ATXN2 TP63 RC3H1 BRD4 UPF1 REST SNRPA	6.42e-05	371	55	7	int:HNRNPAB
Interaction	BMI1 interactions	ATXN2 ZC3H4 PRRC2C BRD4 YLPM1 SEC23IP SMARCA4 SEC31A UPF1	6.70e-05	659	55	9	int:BMI1
Interaction	PRPF31 interactions	PNMA1 GBF1 SF3A1 RC3H1 BRD4 SNRPA RAD21	6.76e-05	374	55	7	int:PRPF31
Interaction	XRN1 interactions	GBF1 ATXN2 RC3H1 ROR2 UPF1 LEPR	7.12e-05	258	55	6	int:XRN1
Interaction	SOX7 interactions	TRIM33 KMT2C ZFHX4 SMARCA4	7.41e-05	82	55	4	int:SOX7
Interaction	KLF4 interactions	KMT2C SMARCA4 UPF1 BCL9 RAD21	7.48e-05	160	55	5	int:KLF4
Interaction	YLPM1 interactions	SF3A1 BRD4 ITSN2 YLPM1 SNRPA	7.48e-05	160	55	5	int:YLPM1
Interaction	SNRPB interactions	MAGI2 PNMA1 ZC3H4 SF3A1 BRD4 YLPM1 UPF1 SNRPA	7.50e-05	517	55	8	int:SNRPB
Interaction	EP300 interactions	TRERF1 NCOA6 ZC3H4 TP63 SF3A1 BRD4 YLPM1 SMARCA4 NR4A3 SEC31A MAML2 UPF1 SNRPA	7.74e-05	1401	55	13	int:EP300
Interaction	MTREX interactions	TRIM33 SF3A1 RC3H1 BRD4 SNRPA RAD21	7.75e-05	262	55	6	int:MTREX
Interaction	PIN1 interactions	STK3 PNMA1 TP63 BRD4 NR4A3 REST LEPR	7.84e-05	383	55	7	int:PIN1
Interaction	QPRT interactions	TRIM33 PRRC2C SF3A1 ZMYM4	8.15e-05	84	55	4	int:QPRT
Interaction	CPSF6 interactions	TRIM33 ZC3H4 TP63 RC3H1 BRD4 ITSN2 YLPM1 TOLLIP	8.45e-05	526	55	8	int:CPSF6
Interaction	GEMIN5 interactions	GBF1 SF3A1 RC3H1 BRD4 SEC23IP SNRPA	8.60e-05	267	55	6	int:GEMIN5
Interaction	TRIM21 interactions	STK3 TRIM33 NEO1 SF3A1 RC3H1 BRD4 YLPM1 TOLLIP NMT1	9.42e-05	689	55	9	int:TRIM21
Interaction	H2BC21 interactions	MRTFB ZC3H4 BRD4 SMARCA4 REST KAT6B ZMYM4 ZMYM3 C2CD2L	1.02e-04	696	55	9	int:H2BC21
Interaction	GATA1 interactions	PNMA1 BRD4 MED14 SMARCA4 BCL9	1.02e-04	171	55	5	int:GATA1
Interaction	FHL3 interactions	TRIM33 MRTFB ATXN2 ROR2 ZMYM4 RAD21	1.03e-04	276	55	6	int:FHL3
Interaction	EPAS1 interactions	TRIM33 MED14 SMARCA4 NR4A3 MED7	1.08e-04	173	55	5	int:EPAS1
Interaction	CTBP1 interactions	KLF10 SOBP BRD4 SEC23IP SEC31A MAML2 NMT1	1.13e-04	406	55	7	int:CTBP1
Interaction	FOXI1 interactions	TRIM33 KMT2C ZFHX4 BCL9	1.16e-04	92	55	4	int:FOXI1
Interaction	SUPT5H interactions	RBM33 ZC3H4 BRD4 MED14 SNRPA MAML3 ZMYM4	1.16e-04	408	55	7	int:SUPT5H
Interaction	TEAD1 interactions	KMT2C ZFHX4 TP63 INSR NR4A3	1.17e-04	176	55	5	int:TEAD1
Interaction	RBFOX2 interactions	ATXN2 SF3A1 TOLLIP UPF1 SNRPA MED7	1.21e-04	284	55	6	int:RBFOX2
Interaction	MED25 interactions	BRD4 MED14 RUSC1 MED7	1.21e-04	93	55	4	int:MED25
Interaction	TOP3B interactions	KMT2C NCOA6 GBF1 KLF10 ATXN2 RBM33 BRD4 MED14 UPF1 BCL9 SNRPA NMT1 C2CD2L	1.26e-04	1470	55	13	int:TOP3B
Interaction	SOX17 interactions	TRIM33 KMT2C NCOA6 BCL9	1.31e-04	95	55	4	int:SOX17
Interaction	ILF3 interactions	TRIM33 ATXN2 PRRC2C RC3H1 BRD4 YLPM1 UPF1 REST SNRPA IL27RA	1.36e-04	896	55	10	int:ILF3
Interaction	CAV1 interactions	TRIM33 NEO1 GBF1 BRD4 ROR2 INSR SEC23IP TOLLIP SEC31A	1.37e-04	724	55	9	int:CAV1
Interaction	SNRPN interactions	SF3A1 RC3H1 UPF1 REST SNRPA	1.52e-04	186	55	5	int:SNRPN
Interaction	TFCP2L1 interactions	TRIM33 BRD4 SMARCA4 ZMYM4	1.54e-04	99	55	4	int:TFCP2L1
Interaction	CCNC interactions	TP63 BRD4 MED14 RUSC1 MED7	1.60e-04	188	55	5	int:CCNC
Interaction	FXR2 interactions	PNMA1 ATXN2 PRRC2C RC3H1 BRD4 UPF1 MED7	1.61e-04	430	55	7	int:FXR2
Interaction	SMAP2 interactions	ATXN2 PRRC2C RC3H1 ROR2 UPF1	1.64e-04	189	55	5	int:SMAP2
Interaction	MED6 interactions	BRD4 MED14 SMARCA4 MED7	1.67e-04	101	55	4	int:MED6
Interaction	SAP18 interactions	RBM33 SF3A1 BRD4 SMARCA4 UPF1 SNRPA	1.78e-04	305	55	6	int:SAP18
Interaction	LHX1 interactions	KMT2C ZFHX4 BCL9 RAD21	1.80e-04	103	55	4	int:LHX1
Interaction	ILF2 interactions	ATXN2 TP63 RC3H1 BRD4 UPF1 REST SNRPA NMT1	1.86e-04	590	55	8	int:ILF2
Cytoband	9q22	ROR2 NR4A3	2.47e-04	19	56	2	9q22
Cytoband	8q22.2	STK3 KLF10	3.64e-04	23	56	2	8q22.2
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	PRR36 BRD4 INSR SMARCA4 UPF1 IL27RA	4.17e-04	797	56	6	chr19p13
GeneFamily	Zinc fingers MYM-type	ZMYM4 ZMYM3	5.43e-05	6	35	2	86
GeneFamily	PHD finger proteins	TRIM33 KMT2C KAT6B	6.96e-04	90	35	3	88
GeneFamily	Ataxins\|Trinucleotide repeat containing	ATXN2 MAML3	1.06e-03	25	35	2	775
GeneFamily	Cyclins\|Mediator complex	MED14 MED7	1.85e-03	33	35	2	1061
GeneFamily	Zinc fingers CCCH-type	ZC3H4 RC3H1	2.08e-03	35	35	2	73
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ITSN2 TOLLIP	2.20e-03	36	35	2	823
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	ROR2 INSR	2.71e-03	40	35	2	321
GeneFamily	Fibronectin type III domain containing	NEO1 INSR IL27RA	3.62e-03	160	35	3	555
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	STK3 TRIM33 KLF10 ATXN2 ZC3H4 PRRC2C WASF3 ITSN2 KAT6B ZMYM4	4.91e-08	466	56	10	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	STK3 TRIM33 GBF1 KLF10 ATXN2 ZC3H4 PRRC2C WASF3 ITSN2 KAT6B ZMYM4	1.64e-06	856	56	11	M4500
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TRIM33 KMT2C GBF1 PRRC2C SF3A1 RAD21	2.36e-06	180	56	6	M8239
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	KMT2C NCOA6 GBF1 PRRC2C BRD4 REST BCL9	5.95e-05	467	56	7	M1347
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TRIM33 BRD4 NR4A3 MAML2 BCL9 KAT6B	6.46e-05	323	56	6	M9150
Coexpression	GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	ATXN2 MED14 NR4A3 ZMYM4 ZMYM3	6.53e-05	198	56	5	M9163
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	ZC3H4 BRD4 INSR RUSC1 BCL9	6.69e-05	199	56	5	M7254
Coexpression	GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	ATXN2 NR4A3 BCL9 ZMYM4 ZMYM3	6.69e-05	199	56	5	M9178
Coexpression	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	PRR36 RC3H1 INSR ZMYM3 IL27RA	6.85e-05	200	56	5	M302
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN	STK3 KLF10 MED14 NR4A3 REST	6.85e-05	200	56	5	M9827
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	KMT2C NCOA6 GBF1 PRRC2C BRD4 REST BCL9	7.44e-05	484	56	7	MM999
Coexpression	BROWNE_HCMV_INFECTION_20HR_UP	TRIM33 GBF1 YLPM1 NR4A3 IL27RA	1.46e-04	235	56	5	M6122
Coexpression	MURARO_PANCREAS_BETA_CELL	KMT2C NEO1 PNMA1 KLF10 ATXN2 MAP6 SOBP BCL9 KAT6B	1.65e-04	946	56	9	M39169
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	ZFHX4 GAS2L3 MAP6 TP63 BRD4 ROR2 INSR MED14 BCL9 KAT6B ZMYM4	7.90e-06	818	56	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	STK3 MAGI2 NEO1 ZFHX4 GAS2L3 ZC3H4 TP63 ROR2 YLPM1 KAT6B LEPR	1.13e-05	850	56	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500	MAGI2 NEO1 ZFHX4 GAS2L3 TP63 ROR2 YLPM1 LEPR	1.55e-05	428	56	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	STK3 MAGI2 NEO1 ZFHX4 GAS2L3 ZC3H4 ROR2 YLPM1	3.42e-05	478	56	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	BNC2 NEO1 AFF2 ZFHX4 ATXN2 SOBP MED14 KAT6B MAML3 ZMYM3	3.66e-05	791	56	10	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	MAGI2 BNC2 NEO1 AFF2 ZFHX4 SOBP ITSN2 MED14 KAT6B ZMYM3	4.16e-05	803	56	10	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500	MAGI2 NEO1 ZFHX4 GAS2L3 ROR2 YLPM1	4.87e-05	249	56	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000	STK3 BNC2 GBF1 ATXN2 SMARCA4 SEC31A REST RAD21	6.54e-05	524	56	8	gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500	MAGI2 ZFHX4 TP63 ROR2 MED14 BCL9 KAT6B	7.14e-05	390	56	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500	BNC2 NEO1 AFF2 ZFHX4 SOBP MED14 ZMYM3	8.90e-05	404	56	7	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	MAGI2 BNC2 NEO1 MRTFB AFF2 ZFHX4 SOBP KAT6B ZMYM3	1.93e-04	783	56	9	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	AFF2 ZFHX4 PRR36 TP63 INSR YLPM1 NR4A3 BCL9 MAML3 RAD21	2.32e-04	989	56	10	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_200	BNC2 ZFHX4 NR4A3	2.43e-04	46	56	3	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_200
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000	STK3 BNC2 GBF1 GAS2L3 ATXN2 SMARCA4 SEC31A REST RAD21	2.69e-04	819	56	9	gudmap_developingGonad_e12.5_testes_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000	BNC2 ZFHX4 NR4A3	2.76e-04	48	56	3	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	MAGI2 BNC2 NEO1 MRTFB AFF2 ZFHX4 SOBP BCL9 KAT6B	2.99e-04	831	56	9	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	MAGI2 BNC2 NEO1 ZFHX4 GAS2L3 TP63 ROR2 YLPM1 KAT6B	3.13e-04	836	56	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	GAS2L3 BRD4 INSR MED14 BCL9 ZMYM4	5.16e-04	385	56	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 MAGI2 BNC2 ZFHX4 ROR2	3.59e-06	185	56	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRERF1 ZFHX4 ROR2 INSR NR4A3	3.78e-06	187	56	5	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	STK3 MAGI2 BNC2 INSR MAML2	4.30e-06	192	56	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRERF1 MAGI2 NEO1 ZFHX4 ROR2	4.64e-06	195	56	5	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	STK3 BNC2 SOBP WASF3 MAML2	4.64e-06	195	56	5	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TRIM33 BRD4 INSR SEC31A REST	5.00e-06	198	56	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PRRC2C BRD4 ITSN2 INSR REST	5.12e-06	199	56	5	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	PRRC2C BRD4 INSR SEC31A REST	5.12e-06	199	56	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	PRRC2C BRD4 INSR SEC31A REST	5.12e-06	199	56	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	SOBP PRRC2C BRD4 SEC31A REST	5.12e-06	199	56	5	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-3\|TCGA-Breast / Sample_Type by Project: Shred V9	KLF10 TP63 NR4A3 LEPR	2.67e-05	137	56	4	3218c787a6b087f74b0804cec14b5ebb713391b7
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	PRRC2C BRD4 INSR REST	2.75e-05	138	56	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 TP63 RUSC1 LEPR	4.78e-05	159	56	4	9f6607e395bcca9cb1c83199bdbbaaa62a93938d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 TP63 RUSC1 LEPR	4.78e-05	159	56	4	c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMELX AFF2 MAP6 SOBP	6.63e-05	173	56	4	3059325901b1e5e12a1a91183f14267288b2f600
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMELX AFF2 MAP6 SOBP	6.63e-05	173	56	4	36c8338463ee4cc432f568728d55989360f9a68d
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	PRRC2C FRMPD3 SNRPA ZMYM4	7.09e-05	176	56	4	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI2 BNC2 ZFHX4 ROR2	7.57e-05	179	56	4	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 MAGI2 ZFHX4 GAS2L3	7.74e-05	180	56	4	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 MAGI2 ZFHX4 GAS2L3	7.74e-05	180	56	4	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 MAGI2 ZFHX4 GAS2L3	7.74e-05	180	56	4	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 MAGI2 BNC2 ROR2	8.25e-05	183	56	4	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 MAGI2 BNC2 ZFHX4	8.25e-05	183	56	4	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI2 BNC2 ZFHX4 ROR2	8.60e-05	185	56	4	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	MAGI2 BNC2 ROR2 LEPR	8.60e-05	185	56	4	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI2 BNC2 TP63 MAML3	9.15e-05	188	56	4	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI2 BNC2 TP63 MAML3	9.15e-05	188	56	4	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	BNC2 SOBP NR4A3 LEPR	9.34e-05	189	56	4	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	BNC2 AFF2 GAS2L3 INSR	9.34e-05	189	56	4	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	ASK428-Epithelial-Transformed_epithelium\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	BNC2 ZFHX4 ROR2 PAPOLB	9.34e-05	189	56	4	87189275234b5d59484c58acbb14a09903f2b578
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	BNC2 SOBP WASF3 MAML2	9.53e-05	190	56	4	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	STK3 BNC2 SOBP MAML2	9.73e-05	191	56	4	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	STK3 SOBP WASF3 MAML2	9.73e-05	191	56	4	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	BNC2 SOBP WASF3 MAML2	9.92e-05	192	56	4	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 ZFHX4 SOBP PRRC2C	9.92e-05	192	56	4	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	BNC2 SOBP WASF3 MAML2	1.01e-04	193	56	4	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ATXN2 RBM33 PRRC2C RAD21	1.01e-04	193	56	4	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI2 BNC2 ROR2 NR4A3	1.01e-04	193	56	4	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	MAGI2 BNC2 SOBP ROR2	1.01e-04	193	56	4	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	BNC2 ROR2 NR4A3 LEPR	1.03e-04	194	56	4	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	STK3 BNC2 SOBP MAML2	1.03e-04	194	56	4	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	STK3 MAGI2 MAML2 MAML3	1.07e-04	196	56	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MAGI2 BNC2 ROR2 MAML2	1.07e-04	196	56	4	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ZFHX4 ROR2 WASF3 LEPR	1.10e-04	197	56	4	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	distal-mesenchymal-Lipofibroblast-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BNC2 ZFHX4 ROR2 NR4A3	1.10e-04	197	56	4	865010edcd7e3f79f505fcef7b33882095994aa8
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ZFHX4 ROR2 WASF3 LEPR	1.10e-04	197	56	4	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	distal-mesenchymal-Lipofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BNC2 ZFHX4 ROR2 NR4A3	1.10e-04	197	56	4	ceb83bdef16b58ee16193413bfb006f7715728b2
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ZFHX4 ROR2 WASF3 LEPR	1.10e-04	197	56	4	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	STK3 MAGI2 MAML2 MAML3	1.12e-04	198	56	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF10 TP63 RC3H1 SEC31A	1.12e-04	198	56	4	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF10 TP63 RC3H1 SEC31A	1.12e-04	198	56	4	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	PRRC2C BRD4 INSR REST	1.14e-04	199	56	4	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI2 KMT2C MAML2 MAML3	1.14e-04	199	56	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	SOBP PRRC2C BRD4 REST	1.14e-04	199	56	4	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	PRRC2C BRD4 INSR REST	1.14e-04	199	56	4	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BRD4 ITSN2 REST RAD21	1.14e-04	199	56	4	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ZFHX4 MAML2 FRMPD3 MAML3	1.16e-04	200	56	4	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	ZFHX4 MAP6 SOBP INSR	1.16e-04	200	56	4	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KMT2C RBM33 PRRC2C ITSN2	1.16e-04	200	56	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	BNC2 TP63 IL27RA	2.33e-04	95	56	3	3699ea16660a22ea79fecfea56ece2dfb0f13467
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	BNC2 TP63 IL27RA	2.33e-04	95	56	3	cbfe615d880913bafaf5e7e8d24c3ec14a9351ce
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	BNC2 TP63 IL27RA	2.33e-04	95	56	3	27ac23b87747434a3084cc087e7b884e68f0eab9
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	TRIM33 YLPM1 SEC23IP BCL9 ZMYM4 IL27RA C2CD2L	4.77e-07	194	56	7	1670_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A	ATXN2 SEC23IP SMARCA4 KAT6B ZMYM4 RAD21 C2CD2L	5.66e-07	199	56	7	1933_DN
Drug	AC1L2XIZ	AMELX BRD4 NMT1	3.05e-06	12	56	3	CID000104803
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	TRIM33 BNC2 MRTFB ZFHX4 ATXN2 KAT6B	3.91e-06	171	56	6	7535_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	BNC2 ZC3H4 KAT6B ZMYM3 IL27RA RAD21	4.32e-06	174	56	6	5940_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BNC2 NCOA6 ZC3H4 KAT6B NMT1 IL27RA	4.93e-06	178	56	6	7245_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A	TP63 INSR YLPM1 SEC23IP TOLLIP UPF1	6.74e-06	188	56	6	1395_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA6 ZC3H4 SF3A1 KAT6B MED7 IL27RA	7.38e-06	191	56	6	7503_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	TRIM33 PRRC2C SEC23IP REST KAT6B NMT1	7.61e-06	192	56	6	3252_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	STK3 GBF1 PRRC2C YLPM1 MED14 KAT6B	8.07e-06	194	56	6	1264_DN
Drug	SC-58125; Up 200; 10uM; HL60; HG-U133A	BNC2 NEO1 AFF2 TP63 NMT1 C2CD2L	8.81e-06	197	56	6	542_UP
Drug	sodium 4-phenylbutyrate; Up 200; 100uM; MCF7; HG-U133A	SOBP TP63 MED14 TOLLIP ZMYM4 C2CD2L	8.81e-06	197	56	6	341_UP
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; HL60; HG-U133A	BNC2 TP63 YLPM1 SEC23IP IL27RA C2CD2L	9.07e-06	198	56	6	1710_UP
Drug	AC1L2E0P	TRERF1 TRIM33 NCOA6 MED14 SMARCA4 NR4A3 KAT6B	9.97e-06	307	56	7	CID000019390
Drug	Melphalan	TRERF1 BNC2 MRTFB ZFHX4 TP63 NR4A3	5.87e-05	276	56	6	ctd:D008558
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BNC2 ZC3H4 KAT6B NMT1 IL27RA	6.67e-05	173	56	5	4565_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BNC2 ZC3H4 KAT6B NMT1 IL27RA	6.86e-05	174	56	5	3993_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA6 ZC3H4 KAT6B NMT1 IL27RA	6.86e-05	174	56	5	1659_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TRIM33 PRRC2C BRD4 SMARCA4 KAT6B	7.44e-05	177	56	5	985_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZC3H4 KAT6B NMT1 ZMYM4 IL27RA	7.84e-05	179	56	5	5822_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BNC2 ZC3H4 KAT6B NMT1 IL27RA	8.05e-05	180	56	5	1793_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	NCOA6 ZC3H4 KAT6B NMT1 IL27RA	8.48e-05	182	56	5	1891_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ZC3H4 KAT6B NMT1 ZMYM3 IL27RA	8.93e-05	184	56	5	7555_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	PRRC2C INSR UPF1 KAT6B RAD21	9.88e-05	188	56	5	6735_DN
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	BNC2 GBF1 NR4A3 REST IL27RA	1.12e-04	193	56	5	1148_UP
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	STK3 GBF1 YLPM1 REST BCL9	1.15e-04	194	56	5	5544_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ZFHX4 TP63 BCL9 NMT1 LEPR	1.15e-04	194	56	5	5418_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; HL60; HT_HG-U133A	BNC2 AFF2 WASF3 ZMYM3 IL27RA	1.17e-04	195	56	5	2151_DN
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	PRR36 ATXN2 BRD4 BCL9 IL27RA	1.17e-04	195	56	5	1688_DN
Drug	17-AAG; Down 200; 1uM; SKMEL5; HG-U133A	KLF10 ATXN2 SOBP NR4A3 BCL9	1.17e-04	195	56	5	505_DN
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A	ZFHX4 ATXN2 ITSN2 UPF1 ZMYM3	1.17e-04	195	56	5	1886_DN
Drug	Lumicolchicine gamma [6901-14-0]; Up 200; 10uM; HL60; HT_HG-U133A	BNC2 SEC23IP NR4A3 KAT6B NMT1	1.20e-04	196	56	5	1317_UP
Drug	cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A	KLF10 INSR NMT1 MAML3 C2CD2L	1.20e-04	196	56	5	379_UP
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	BRD4 INSR YLPM1 IL27RA C2CD2L	1.20e-04	196	56	5	1629_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; HL60; HT_HG-U133A	MRTFB INSR KAT6B NMT1 C2CD2L	1.20e-04	196	56	5	2424_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HG-U133A	ATXN2 ITSN2 YLPM1 NMT1 RAD21	1.20e-04	196	56	5	428_UP
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	GBF1 BRD4 SMARCA4 UPF1 IL27RA	1.20e-04	196	56	5	5341_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	BNC2 BRD4 YLPM1 SMARCA4 IL27RA	1.20e-04	196	56	5	3144_UP
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A	PRR36 SF3A1 BRD4 UPF1 BCL9	1.20e-04	196	56	5	1679_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	YLPM1 TOLLIP UPF1 BCL9 C2CD2L	1.23e-04	197	56	5	5819_DN
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	ZFHX4 TP63 YLPM1 NR4A3 C2CD2L	1.23e-04	197	56	5	3098_UP
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	BRD4 INSR SEC23IP MED14 REST	1.23e-04	197	56	5	7230_DN
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; HL60; HT_HG-U133A	STK3 MRTFB GBF1 SF3A1 KAT6B	1.23e-04	197	56	5	3068_DN
Drug	copper(II) sulfate pentahydrate; Down 200; 100uM; PC3; HG-U133A	TP63 SF3A1 TOLLIP NMT1 IL27RA	1.26e-04	198	56	5	459_DN
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A	STK3 SMARCA4 BCL9 NMT1 ZMYM3	1.26e-04	198	56	5	5533_DN
Drug	HA-1077 dihydrochloride; Down 200; 10uM; PC3; HG-U133A	ATXN2 TP63 BCL9 MED7 C2CD2L	1.26e-04	198	56	5	436_DN
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A	BNC2 GBF1 REST ZMYM3 IL27RA	1.29e-04	199	56	5	1270_UP
Drug	Metronidazole [443-48-1]; Up 200; 23.4uM; HL60; HG-U133A	AFF2 YLPM1 MED14 NMT1 C2CD2L	1.29e-04	199	56	5	2003_UP
Drug	Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	TRIM33 MED14 KAT6B ZMYM3 C2CD2L	1.29e-04	199	56	5	7030_DN
Drug	Troleandomycin [2751-09-9]; Down 200; 5uM; HL60; HG-U133A	ATXN2 ITSN2 SEC23IP ZMYM4 IL27RA	1.29e-04	199	56	5	1965_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SEC23IP MED14 REST BCL9 C2CD2L	1.29e-04	199	56	5	7211_DN
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; HL60; HG-U133A	ITSN2 YLPM1 SMARCA4 UPF1 RAD21	1.29e-04	199	56	5	1386_UP
Drug	tolbutamide; Up 200; 100uM; MCF7; HG-U133A	STK3 AFF2 SEC23IP NMT1 ZMYM4	1.29e-04	199	56	5	142_UP
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	STK3 ATXN2 YLPM1 NMT1 C2CD2L	1.32e-04	200	56	5	4959_DN
Drug	2-(ethylsulfonyl)ethanol	AFF2 SF3A1 ITSN2 UPF1 SNRPA	1.66e-04	210	56	5	CID000010549
Drug	2-hydroxypalmitic acid	NCOA6 NMT1	2.12e-04	9	56	2	CID000092836
Disease	short bowel syndrome (biomarker_via_orthology)	INSR LEPR	3.41e-06	2	55	2	DOID:10605 (biomarker_via_orthology)
Disease	Congenital muscular hypertrophy-cerebral syndrome	BRD4 RAD21	3.40e-05	5	55	2	C1802395
Disease	Cornelia de Lange Syndrome 3	BRD4 RAD21	3.40e-05	5	55	2	C1853099
Disease	Cornelia de Lange Syndrome 1	BRD4 RAD21	3.40e-05	5	55	2	C4551851
Disease	De Lange syndrome	BRD4 RAD21	5.09e-05	6	55	2	cv:C0270972
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	MAGI2 BNC2 ZC3H4 YLPM1 NMT1 MAML3	5.89e-05	364	55	6	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Cornelia De Lange Syndrome	BRD4 RAD21	9.48e-05	8	55	2	C0270972
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	WASF3 NR4A3 MAML2 KAT6B	1.06e-04	131	55	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	WASF3 NR4A3 MAML2 KAT6B	1.06e-04	131	55	4	C4552091
Disease	Juvenile arthritis	WASF3 NR4A3 MAML2 KAT6B	1.06e-04	131	55	4	C3495559
Disease	Juvenile psoriatic arthritis	WASF3 NR4A3 MAML2 KAT6B	1.06e-04	131	55	4	C3714758
Disease	ovarian neoplasm	BNC2 TP63 SMARCA4 BCL9	1.16e-04	134	55	4	C0919267
Disease	Juvenile-Onset Still Disease	WASF3 NR4A3 MAML2 KAT6B	1.19e-04	135	55	4	C0087031
Disease	Malignant neoplasm of ovary	BNC2 TP63 SMARCA4 BCL9	1.26e-04	137	55	4	C1140680
Disease	obsolete_red blood cell distribution width	TRIM33 NEO1 ZC3H4 PRRC2C RC3H1 BRD4 INSR YLPM1 REST NMT1	1.70e-04	1347	55	10	EFO_0005192
Disease	Insulin Sensitivity	INSR NR4A3 LEPR	1.94e-04	60	55	3	C0920563
Disease	Insulin Resistance	INSR NR4A3 LEPR	1.94e-04	60	55	3	C0021655
Disease	neutrophil count	TRERF1 TRIM33 BNC2 ATXN2 RC3H1 ITSN2 REST BCL9 LEPR ZMYM4	2.09e-04	1382	55	10	EFO_0004833
Disease	chronic kidney disease (implicated_via_orthology)	INSR LEPR	2.22e-04	12	55	2	DOID:784 (implicated_via_orthology)
Disease	body fat percentage	MAGI2 BNC2 ZC3H4 YLPM1 NMT1 MAML3	2.90e-04	488	55	6	EFO_0007800
Disease	Diabetic Asymmetric Polyneuropathy	INSR LEPR	3.06e-04	14	55	2	C0393835
Disease	Diabetic Neuralgia	INSR LEPR	3.06e-04	14	55	2	C0751074
Disease	Diabetic Neuropathies	INSR LEPR	3.06e-04	14	55	2	C0011882
Disease	Sarcoma, Spindle Cell	SMARCA4 MAML3	3.06e-04	14	55	2	C0205945
Disease	Sarcoma, Epithelioid	SMARCA4 MAML3	3.06e-04	14	55	2	C0205944
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	INSR LEPR	3.06e-04	14	55	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	INSR LEPR	3.06e-04	14	55	2	C0271673
Disease	Diabetic Mononeuropathy	INSR LEPR	3.06e-04	14	55	2	C0271678
Disease	Diabetic Autonomic Neuropathy	INSR LEPR	3.06e-04	14	55	2	C0271686
Disease	Diabetic Amyotrophy	INSR LEPR	3.06e-04	14	55	2	C0271685
Disease	Diabetic Polyneuropathies	INSR LEPR	3.06e-04	14	55	2	C0271680
Disease	lipoprotein measurement, phospholipid measurement	ATXN2 SMARCA4 LEPR	5.43e-04	85	55	3	EFO_0004639, EFO_0004732
Disease	lipid measurement, lipoprotein measurement	ATXN2 SMARCA4 LEPR	6.42e-04	90	55	3	EFO_0004529, EFO_0004732
Disease	Sarcoma	SMARCA4 MAML3	7.00e-04	21	55	2	C1261473
Disease	Carcinoma of lung	TP63 RAD21	8.42e-04	23	55	2	C0684249
Disease	Adenoid Cystic Carcinoma	MAGI2 KMT2C MAML3	8.72e-04	100	55	3	C0010606
Disease	gastroesophageal reflux disease	ATXN2 YLPM1 MAML3	8.97e-04	101	55	3	EFO_0003948
Disease	Impaired glucose tolerance	INSR LEPR	9.96e-04	25	55	2	C0271650
Disease	type 2 diabetes mellitus (implicated_via_orthology)	AFF2 INSR LEPR	1.00e-03	105	55	3	DOID:9352 (implicated_via_orthology)
Disease	Endogenous Hyperinsulinism	INSR LEPR	1.08e-03	26	55	2	C1257963
Disease	Exogenous Hyperinsulinism	INSR LEPR	1.08e-03	26	55	2	C1257964
Disease	Compensatory Hyperinsulinemia	INSR LEPR	1.08e-03	26	55	2	C1257965
Disease	Sezary Syndrome	KMT2C SMARCA4	1.16e-03	27	55	2	C0036920
Disease	free cholesterol measurement	ATXN2 SMARCA4 LEPR	1.24e-03	113	55	3	EFO_0008591
Disease	Hyperinsulinism	INSR LEPR	1.25e-03	28	55	2	C0020459
Disease	low density lipoprotein cholesterol measurement, lipid measurement	ATXN2 SMARCA4 LEPR	1.27e-03	114	55	3	EFO_0004529, EFO_0004611
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	ATXN2 SMARCA4 LEPR	1.27e-03	114	55	3	EFO_0004574, EFO_0004611
Disease	Hyperglycemia, Postprandial	INSR LEPR	1.44e-03	30	55	2	C1855520
Disease	Hyperglycemia	INSR LEPR	1.44e-03	30	55	2	C0020456
Disease	diastolic blood pressure, systolic blood pressure	TRIM33 BNC2 ATXN2 RBM33 BRD4 BCL9	1.51e-03	670	55	6	EFO_0006335, EFO_0006336
Disease	C-reactive protein measurement	TRERF1 BNC2 NCOA6 NEO1 KLF10 SMARCA4 MAML3 LEPR	1.68e-03	1206	55	8	EFO_0004458
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	ATXN2 SMARCA4 LEPR	1.70e-03	126	55	3	EFO_0004611, EFO_0010351
Disease	cutaneous squamous cell carcinoma	BNC2 TP63	1.74e-03	33	55	2	EFO_1001927
Disease	esterified cholesterol measurement	ATXN2 SMARCA4 LEPR	1.77e-03	128	55	3	EFO_0008589
Disease	systolic blood pressure, body mass index	ATXN2 BCL9	1.84e-03	34	55	2	EFO_0004340, EFO_0006335
Disease	choline measurement	ATXN2 SMARCA4 LEPR	1.85e-03	130	55	3	EFO_0010116

Protein segments in the cluster

Peptide	Gene	Start	Entry
QQPVIPQQPMMPVPG	AMELX	91	Q99217
MFPMQPLPPMLPDLT	AMELX	161	Q99217
PPPSMPQQAAPAMKS	BRD4	781	O60885
PPPSEPVVPAVMMAT	BNC2	606	Q6ZN30
ISLPPPIIQPMEVQM	AFF2	556	P51816
PPMPVTKPLQMVPRG	RC3H1	566	Q5TC82
ETPRMMMTPPPVTPQ	RBM33	366	Q96EV2
MMTPPPVTPQQPKNI	RBM33	371	Q96EV2
EPVMPPQQVEQMEIP	RAD21	486	O60216
PVVLPPIMKQPPMFS	ITSN2	96	Q9NZM3
GTNLPPLMMPTPLVP	ITSN2	146	Q9NZM3
ATMTPPPNLTPPPMN	KAT6B	1876	Q8WYB5
MMPFPVTTQGPPQPA	PAPOLB	1	Q9NRJ5
VQVEPPPPMEHAQME	REST	626	Q13127
APPTMMPSVQPQPPL	KMT2C	3276	Q8NEZ4
PPTMSQPTFPMVPQQ	KMT2C	3296	Q8NEZ4
NSMVPPLAIMERPPP	MAGI2	521	Q86UL8
IPEPVKNQAPMVPAP	MAP6	566	Q96JE9
ETAVKPPAPPLPQMM	NMT1	6	P30419
MTPPVANPNKNPLMP	MAML3	616	Q96JK9
PNMMYPVPVSPGVQP	ATXN2	966	Q99700
MGEPQQVSALPPPPM	MED7	1	O43513
KMPQAFEPPMPPPCQ	C9orf131	331	Q5VYM1
PPQVQMAPPVSLEPM	MRTFB	946	Q9ULH7
MEPPPVMESSQPAQA	IL27RA	591	Q6UWB1
LMSVQPINMVKPDPP	LEPR	226	P48357
PGRPPPTLQEMIQMA	INSR	1126	P06213
SQTMPTNMPPPRKLP	MED14	1151	O60244
PPNQLTPAVQMRPMN	MAML2	1016	Q8IZL2
MPPQLMQHVAPPPQP	NCOA6	986	Q14686
MTPPPQGAVIRAMPV	TP63	216	Q9H3D4
NIPIPFNLVMPPMPP	UPF1	991	Q92900
LVPSEKPPMMPQAQP	C2CD2L	266	O14523
MVFSRPASQPLPPPM	FRMPD3	496	Q5JV73
TPQPPEMNPLSAVNM	GAS2L3	311	Q86XJ1
SGPNPVVPMPTLSPM	BCL9	1066	O00512
VIQDPMPMEPQGQKP	GBF1	1721	Q92538
GVPPMPVICQMVPLP	KLF10	266	Q13118
QNPTPTPGPEMPAEM	PNMA1	126	Q8ND90
PSQPSPPSPPICMMN	NR4A3	386	Q92570
PPGPPPALQQTMQAM	RUSC1	681	Q9BVN2
LQQMRMQQPPAPVPT	TRIM33	531	Q9UPN9
QAPPSMTTPPMQAPP	PRR36	566	Q9H6K5
INAPYTPVPDPTPMM	NEO1	841	Q92859
QRPPMALASQMPPPL	PRRC2C	2756	Q9Y520
PGMQQQMPTLPPPSV	SMARCA4	211	P51532
FIPMKGQIRPMVPPP	ROR2	801	Q01974
MAPQQVPPQMVPKPS	ROR2	846	Q01974
QMYQMPPGSLPPVPS	SEC23IP	221	Q9Y6Y8
VMPRPPMASVVRLPP	SF3A1	596	Q15459
INVVPMPPSAPPIMA	SF3A1	626	Q15459
PMRAIFMIPTNPPPT	STK3	226	Q13188
IMMQPVQHPALPPQL	ZFHX4	2036	Q86UP3
PPVSMMPNGPMPVPQ	SOBP	491	A7XYQ1
PAAMVMPPQPVVLMP	TOLLIP	176	Q9H0E2
MPPQPVVLMPTVYQQ	TOLLIP	181	Q9H0E2
QTAFVSPLQMPMQPP	WASF3	356	Q9UPY6
SPLQMPMQPPFPASA	WASF3	361	Q9UPY6
GMPPMSKPPPVQQTV	YLPM1	1626	P49750
QMPMPVHEPLSPQQL	ZC3H4	556	Q9UPT8
PENFMPPVPITSPIM	SEC31A	1011	O94979
MPGQMPPAQPLSENP	SNRPA	191	P09012
VPVPFSMPIPVPVPM	ZMYM3	886	Q14202
GIPVPMPVPMLIPSS	ZMYM4	1006	Q5VZL5
PMVMPVSVPVKLLPP	TRERF1	581	Q96PN7